INTRODUCTION: The causes of relapse in patients with Crohn's disease (CD) and ulcerative colitis (UC) are largely unknown. This paper reviews the epidemiological and clinical data on how medications (non-steroidal anti-inflammatory drugs, estrogens and antibiotics), lifestyle factors (smoking, psychological stress, diet and air pollution) may precipitate clinical relapses and recurrence. Potential biological mechanisms include: increasing thrombotic tendency, imbalances in prostaglandin synthesis, alterations in the composition of gut microbiota, and mucosal damage causing increased permeability. RESULTS: The clinical epidemiological data consistently reports positive associations between smoking and relapses in CD, and inverse ones with UC. For NSAIDs and estrogens, the epidemiological findings are inconsistent, although general antibiotic use was associated with a reduced risk of relapse in CD. High levels of stress were positively associated with relapse, although psychological interventions did not have therapeutic benefits. The limited work on diet has reported sulphur-containing foods are positively associated with relapse in UC, but there is no work in CD. Ecological data reported positive correlations between air pollution levels and IBD hospitalisations. CONCLUSIONS: In the future, to clarify this area, more clinical epidemiological work is required where detailed drug types and doses, and complete dietary intakes are measured, in specific forms of IBD. Such work could provide guidance to both patients and doctors to help maintain remission.
INTRODUCTION: The causes of relapse in patients with Crohn's disease (CD) and ulcerative colitis (UC) are largely unknown. This paper reviews the epidemiological and clinical data on how medications (non-steroidal anti-inflammatory drugs, estrogens and antibiotics), lifestyle factors (smoking, psychological stress, diet and air pollution) may precipitate clinical relapses and recurrence. Potential biological mechanisms include: increasing thrombotic tendency, imbalances in prostaglandin synthesis, alterations in the composition of gut microbiota, and mucosal damage causing increased permeability. RESULTS: The clinical epidemiological data consistently reports positive associations between smoking and relapses in CD, and inverse ones with UC. For NSAIDs and estrogens, the epidemiological findings are inconsistent, although general antibiotic use was associated with a reduced risk of relapse in CD. High levels of stress were positively associated with relapse, although psychological interventions did not have therapeutic benefits. The limited work on diet has reported sulphur-containing foods are positively associated with relapse in UC, but there is no work in CD. Ecological data reported positive correlations between air pollution levels and IBD hospitalisations. CONCLUSIONS: In the future, to clarify this area, more clinical epidemiological work is required where detailed drug types and doses, and complete dietary intakes are measured, in specific forms of IBD. Such work could provide guidance to both patients and doctors to help maintain remission.
Authors: Marian C Aldhous; Robin J Prescott; Simon Roberts; Kay Samuel; Martin Waterfall; Jack Satsangi Journal: Inflamm Bowel Dis Date: 2008-11 Impact factor: 5.325
Authors: A P Dhillon; A Anthony; R Sim; A J Wakefield; E A Sankey; M Hudson; M C Allison; R E Pounder Journal: Histopathology Date: 1992-08 Impact factor: 5.087
Authors: Elizabeth A Magee; Laurie M Edmond; Shiona M Tasker; San Choon Kong; Richard Curno; John H Cummings Journal: Nutr J Date: 2005-02-10 Impact factor: 3.271
Authors: Håkan Törnqvist; Nicholas L Mills; Manuel Gonzalez; Mark R Miller; Simon D Robinson; Ian L Megson; William Macnee; Ken Donaldson; Stefan Söderberg; David E Newby; Thomas Sandström; Anders Blomberg Journal: Am J Respir Crit Care Med Date: 2007-04-19 Impact factor: 21.405
Authors: Jennifer Aa DeLuca; Kimberly F Allred; Rani Menon; Rebekah Riordan; Brad R Weeks; Arul Jayaraman; Clinton D Allred Journal: Exp Biol Med (Maywood) Date: 2018-06-06
Authors: Matteo M Pusceddu; Mariana Barboza; Ciara E Keogh; Melinda Schneider; Patricia Stokes; Jessica A Sladek; Hyun Jung D Kim; Cristina Torres-Fuentes; Lily R Goldfild; Shane E Gillis; Ingrid Brust-Mascher; Gonzalo Rabasa; Kyle A Wong; Carlito Lebrilla; Mariana X Byndloss; Charles Maisonneuve; Andreas J Bäumler; Dana J Philpott; Richard L Ferrero; Kim E Barrett; Colin Reardon; Mélanie G Gareau Journal: J Physiol Date: 2019-11-27 Impact factor: 5.182
Authors: Jonas Zeitz; Nicolas Fournier; Christian Labenz; Luc Biedermann; Pascal Frei; Benjamin Misselwitz; Sylvie Scharl; Stephan R Vavricka; Michael C Sulz; Michael Fried; Gerhard Rogler; Michael Scharl Journal: Inflamm Intest Dis Date: 2017-02-25